CD274 and neoplasm: Notably, a tumor cell proportion score (TPS) of ≥1% has been linked to substantial benefits in extending overall survival compared to TPS < 1%, suggesting this threshold as a potential predictor of the efficacy of PD-1/PD-L1 inhibitors (37).